Literature DB >> 28905353

Platelet RNA in Cancer Diagnostics.

Lee-Ann Tjon-Kon-Fat1, Nik Sol2, Thomas Wurdinger3,4, R Jonas A Nilsson1.   

Abstract

Platelets are involved in several steps of cancer metastasis. During this process, platelets are exposed to the tumor and its environment, thereby exchanging biomolecules with the tumor cells and resulting in tumor-mediated "education" of the platelets and a change in their RNA profile. Analysis of platelet RNA profiles or direct measurement of tumor-derived biomarkers within platelets can provide information on ongoing cancer-related processes in the individual (e.g., whether the patient has cancer, the tumor type, and possibly identify oncogenic alterations driving the disease for treatment selection). The close interaction with the disease process and the ability to respond to systemic alterations make platelets an interesting biosource for implementation in precision medicine. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28905353     DOI: 10.1055/s-0037-1606182

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

Review 1.  Toward platelet transcriptomics in cancer diagnosis, prognosis and therapy.

Authors:  Anandi Krishnan; Sally Thomas
Journal:  Br J Cancer       Date:  2021-11-22       Impact factor: 9.075

Review 2.  Bone Marrow Defects and Platelet Function: A Focus on MDS and CLL.

Authors:  Sarah Luu; Elizabeth E Gardiner; Robert K Andrews
Journal:  Cancers (Basel)       Date:  2018-05-18       Impact factor: 6.639

3.  Delivery of platelet TPM3 mRNA into breast cancer cells via microvesicles enhances metastasis.

Authors:  Bing Yao; Shuang Qu; Ruifeng Hu; Wen Gao; Shidai Jin; Junyi Ju; Quan Zhao
Journal:  FEBS Open Bio       Date:  2019-11-21       Impact factor: 2.693

Review 4.  Circulating platelets as liquid biopsy sources for cancer detection.

Authors:  Mafalda Antunes-Ferreira; Danijela Koppers-Lalic; Thomas Würdinger
Journal:  Mol Oncol       Date:  2020-12-14       Impact factor: 6.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.